A Study of Pembrolizumab and Bavituximab in Patients With Advanced Hepatocellular Carcinoma
Clinical trial NCT03519997 · COMPLETED
Trial details
- NCT number
- NCT03519997
- Sponsor
- David Hsieh
- Status
- COMPLETED
- Phase
- Phase 2
- Study type
- INTERVENTIONAL
- Start date
- 2018-04-26
- Primary completion
- 2023-04-21
- Enrollment
- 35
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.